ReviewLeukemia2020
Should persons with acute myeloid leukemia (AML) in 1st histological complete remission who are measurable residual disease (MRD) test positive receive an allotransplant?
Adriano Venditti et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
16 papers cite it
this papercites it